TM
Congress trade
Rep. Tom Malinowski (D-NJ) bought $15K-$50K of Merck & Company, Inc. (MRK) stock
Tom Malinowski, U.S. Representative (D-NJ), disclosed a purchase of Merck & Company, Inc. (MRK) stock worth $15K-$50K in a STOCK Act filing on Jul 9, 2021.
The trade happened on Aug 24, 2020, 319 days before it was made public.
MRK has moved +77.0% since the trade date, from $81.51 to $144.30 (Oct 2, 2026 close).
- Traded
- Aug 24, 2020
- Disclosed
- Jul 9, 2021
- Filing delay
- 319 days
- Price since
- +77.0%
- Source
- STOCK Act disclosure
Other trades in this disclosure (60)
- SellRHT$50K-$100KJul 9, 2021
- BuyBL$15K-$50KJul 9, 2021
- SellBL$15K-$50KJul 9, 2021
- BuyBRBR$15K-$50KJul 9, 2021
- BuyCCL$15K-$50KJul 9, 2021
- SellCCL$15K-$50KJul 9, 2021
- SellDOMO$15K-$50KJul 9, 2021
- SellEPD$15K-$50KJul 9, 2021
- SellEQIX$15K-$50KJul 9, 2021
- SellEQIX$15K-$50KJul 9, 2021
- SellEVBG$15K-$50KJul 9, 2021
- BuyFRT$15K-$50KJul 9, 2021
- SellFRT$15K-$50KJul 9, 2021
- SellINST$15K-$50KJul 9, 2021
- BuyK$15K-$50KJul 9, 2021
- SellK$15K-$50KJul 9, 2021
- SellMAC$15K-$50KJul 9, 2021
- SellMDXG$15K-$50KJul 9, 2021
- SellMRK$15K-$50KJul 9, 2021
- SellPLAY$15K-$50KJul 9, 2021
More MRK insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.